177 related articles for article (PubMed ID: 33131079)
1. Youth and non-European ethnicity are associated with increased loss of publicly funded insulin pump access in New Zealand people with type 1 diabetes.
Hennessy LD; De Lange M; Wiltshire EJ; Jefferies C; Wheeler BJ
Diabet Med; 2021 Jan; 38(1):e14450. PubMed ID: 33131079
[TBL] [Abstract][Full Text] [Related]
2. District health board of residence, ethnicity and socioeconomic status all impact publicly funded insulin pump uptake in New Zealand patients with type 1 diabetes.
Wheeler BJ; Braund R; Galland B; Mikuscheva A; Wiltshire E; Jefferies C; de Lange M
N Z Med J; 2019 Mar; 132(1491):78-89. PubMed ID: 30845131
[TBL] [Abstract][Full Text] [Related]
3. Demographic and regional disparities in insulin pump utilization in a setting of universal funding: a New Zealand nationwide study.
McKergow E; Parkin L; Barson DJ; Sharples KJ; Wheeler BJ
Acta Diabetol; 2017 Jan; 54(1):63-71. PubMed ID: 27650535
[TBL] [Abstract][Full Text] [Related]
4. Frailty of Māori, Pasifika, and Non-Māori/Non-Pasifika Older People in New Zealand: A National Population Study of Older People Referred for Home Care Services.
Abey-Nesbit R; Peel NM; Matthews H; Hubbard RE; Nishtala PS; Bergler U; Deely JM; Pickering JW; Schluter PJ; Jamieson HA
J Gerontol A Biol Sci Med Sci; 2021 May; 76(6):1101-1107. PubMed ID: 33075128
[TBL] [Abstract][Full Text] [Related]
5. Insulin pump special eligibility criteria in New Zealand: a survey of prescriber opinion and practice.
Groves M; Styles S; de Bock M
N Z Med J; 2022 Apr; 135():82-88. PubMed ID: 35728187
[TBL] [Abstract][Full Text] [Related]
6. Availability of and access to continuous subcutaneous insulin infusion therapy for adults with type 1 diabetes in Ireland.
Gajewska KA; Biesma R; Bennett K; Sreenan S
Acta Diabetol; 2020 Jul; 57(7):875-882. PubMed ID: 32124077
[TBL] [Abstract][Full Text] [Related]
7. Low uptake of continuous subcutaneous insulin infusion therapy in people with type 1 diabetes in Ireland: a retrospective cross-sectional study.
Gajewska KA; Bennett K; Biesma R; Sreenan S
BMC Endocr Disord; 2020 Jun; 20(1):92. PubMed ID: 32576284
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of diabetes in New Zealand general practice: the influence of ethnicity and social deprivation.
Joshy G; Porter T; Le Lievre C; Lane J; Williams M; Lawrenson R
J Epidemiol Community Health; 2009 May; 63(5):386-90. PubMed ID: 19211590
[TBL] [Abstract][Full Text] [Related]
9. Barriers and facilitators to accessing insulin pump therapy by adults with type 1 diabetes mellitus: a qualitative study.
Gajewska KA; Biesma R; Bennett K; Sreenan S
Acta Diabetol; 2021 Jan; 58(1):93-105. PubMed ID: 32862261
[TBL] [Abstract][Full Text] [Related]
10. Continuous subcutaneous insulin infusion versus multiple daily injection regimens in children and young people at diagnosis of type 1 diabetes: pragmatic randomised controlled trial and economic evaluation.
Blair JC; McKay A; Ridyard C; Thornborough K; Bedson E; Peak M; Didi M; Annan F; Gregory JW; Hughes DA; Gamble C;
BMJ; 2019 Apr; 365():l1226. PubMed ID: 30944112
[TBL] [Abstract][Full Text] [Related]
11. Health status of New Zealand European, Maori, and Pacific patients with diabetes at 242 New Zealand general practices.
Tomlin A; Tilyard M; Dawson A; Dovey S
N Z Med J; 2006 Jun; 119(1235):U2004. PubMed ID: 16751827
[TBL] [Abstract][Full Text] [Related]
12. Analysis of deprivation distribution in New Zealand by ethnicity, 1991-2013.
Loring B; Paine SJ; Robson B; Reid P
N Z Med J; 2022 Nov; 135(1565):31-40. PubMed ID: 36356267
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of Type 1 diabetes in New Zealanders aged 0-24 years.
Wu D; Kendall D; Lunt H; Willis J; Darlow B; Frampton C
N Z Med J; 2005 Jul; 118(1218):U1557. PubMed ID: 16027748
[TBL] [Abstract][Full Text] [Related]
14. Ethnic Differences in Cancer Rates Among Adults With Type 2 Diabetes in New Zealand From 1994 to 2018.
Yu D; Wang Z; Cai Y; McBride K; Osuagwu UL; Pickering K; Baker J; Cutfield R; Orr-Walker BJ; Sundborn G; Jameson MB; Zhao Z; Simmons D
JAMA Netw Open; 2022 Feb; 5(2):e2147171. PubMed ID: 35129595
[TBL] [Abstract][Full Text] [Related]
15. Impact of Medicare Continuous Subcutaneous Insulin Infusion Policies in Patients With Type 1 Diabetes.
Argento NB; Liu J; Hughes AS; McAuliffe-Fogarty AH
J Diabetes Sci Technol; 2020 Mar; 14(2):257-261. PubMed ID: 30931609
[TBL] [Abstract][Full Text] [Related]
16. Greater insulin response to acute fructose ingestion among Māori and Pacific people compared to European people living in Aotearoa New Zealand.
Murphy R; Gamble GD; House M; Pool B; Horne A; Merriman TR; Dalbeth N
Intern Med J; 2019 Feb; 49(2):196-202. PubMed ID: 30298971
[TBL] [Abstract][Full Text] [Related]
17. Insulin pump treatment; increasing prevalence, and predictors for better metabolic outcome in Danish children and adolescents with type 1 diabetes.
Olsen B; Johannesen J; Fredheim S; Svensson J;
Pediatr Diabetes; 2015 Jun; 16(4):256-62. PubMed ID: 25082292
[TBL] [Abstract][Full Text] [Related]
18. Trends in deprivation in hospitalisations of Indigenous children and young people in Aotearoa New Zealand.
Oben G; Crengle S; Kokaua J; Duncanson M
J Paediatr Child Health; 2022 Aug; 58(8):1345-1351. PubMed ID: 35426459
[TBL] [Abstract][Full Text] [Related]
19. Ethnicity and social deprivation independently influence metabolic control in children with type 1 diabetes.
Carter PJ; Cutfield WS; Hofman PL; Gunn AJ; Wilson DA; Reed PW; Jefferies C
Diabetologia; 2008 Oct; 51(10):1835-42. PubMed ID: 18679654
[TBL] [Abstract][Full Text] [Related]
20. Flexible insulin therapy with a hybrid regimen of insulin degludec and continuous subcutaneous insulin infusion with pump suspension before exercise in physically active adults with type 1 diabetes (FIT Untethered): a single-centre, open-label, proof-of-concept, randomised crossover trial.
Aronson R; Li A; Brown RE; McGaugh S; Riddell MC
Lancet Diabetes Endocrinol; 2020 Jun; 8(6):511-523. PubMed ID: 32445738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
